Order Article Reprints

Pîrlog C-F, Costache R, Paroșanu AI, Slavu CO, Olaru M, Popa AM, Iaciu C, Niță I, Moțatu P, Cotan HT, et al. Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors? Diagnostics. 2023; 13(11):1892. https://doi.org/10.3390/diagnostics13111892

Pîrlog, Cristina-Florina, Raluca Costache, Andreea Ioana Paroșanu, Cristina Orlov Slavu, Mihaela Olaru, Ana Maria Popa, Cristian Iaciu, Irina Niță, Pompilia Moțatu, Horia Teodor Cotan, and et al. 2023. "Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?" Diagnostics 13, no. 11: 1892. https://doi.org/10.3390/diagnostics13111892

Pîrlog, C.-F., Costache, R., Paroșanu, A. I., Slavu, C. O., Olaru, M., Popa, A. M., Iaciu, C., Niță, I., Moțatu, P., Cotan, H. T., Oprița, A. V., Costache, D., Manolescu, L. S. C., & Nițipir, C. (2023). Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors? Diagnostics, 13(11), 1892. https://doi.org/10.3390/diagnostics13111892